Individual responses to a single oral dose of albendazole indicate reduced efficacy against soil-transmitted helminths in an area with high drug pressure

Martin Walker, Piet Cools, Marco Albonico, Shaali M Ame, Mio Ayana, Daniel Dana, Jennifer Keiser, Leonardo F Matoso, Antonio Montresor, Zeleke Mekonnen, Rodrigo Corrêa-Oliveira, Simone A Pinto, Somphou Sayasone, Jozef Vercruysse, Johnny Vlaminck, Bruno Levecke, Martin Walker, Piet Cools, Marco Albonico, Shaali M Ame, Mio Ayana, Daniel Dana, Jennifer Keiser, Leonardo F Matoso, Antonio Montresor, Zeleke Mekonnen, Rodrigo Corrêa-Oliveira, Simone A Pinto, Somphou Sayasone, Jozef Vercruysse, Johnny Vlaminck, Bruno Levecke

Abstract

Background: Albendazole (ALB) is administered annually to millions of children through global deworming programs targeting soil-transmitted helminths (STHs: Ascaris lumbricoides, Trichuris trichiura and hookworms, Necator americanus and Ancylostoma duodenale). However, due to the lack of large individual patient datasets collected using standardized protocols and the application of population-based statistical methods, little is known about factors that may affect individual responses to treatment.

Methodology/principal findings: We re-analyzed 645 individual patient data from three standardized clinical trials designed to assess the efficacy of a single 400 mg oral dose of ALB against STHs in schoolchildren from different study sites, each with varying history of drug pressure based on duration of mass drug administration programs: Ethiopia, low; Lao People's Democratic Republic (PDR), moderate; Pemba Island (Tanzania), high. Using a Bayesian statistical modelling approach to estimate individual responses (individual egg reduction rates, ERRi), we found that efficacy was lower in Pemba Island, particularly for T. trichiura. For this STH, the proportion of participants with a satisfactory response (ERRi ≥50%), was 65% in Ethiopia, 61% in Lao PDR but only 29% in Pemba Island. There was a significant correlation between ERRi and infection intensity prior to drug administration (ERRi decreasing as a function of increasing infection intensity). Individual age and sex also affected the drug response, but these were of negligible clinical significance and not consistent across STHs and study sites.

Conclusions/significance: We found decreased efficacy of ALB against all the STHs analyzed in Pemba Island (Tanzania), an area with high drug pressure. This does not indicate causality, as this association may also be partially explained by differences in infection intensity prior to drug administration. Notwithstanding, our results indicate that without alternative treatment regimens, program targets will not be achievable on Pemba Island because of inadequate efficacy of ALB.

Trial registration: The study was registered on Clinicaltrials.gov (ID: NCT03465488) on March 7, 2018.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Mean fecal egg count per…
Fig 1. Mean fecal egg count per individual before and after administration of a single oral dose albendazole.
The mean number of eggs counted across duplicate Kato-Katz slides from one stool sample for each individual (mean fecal egg count) before (baseline) and after administration of a single 400 mg oral dose of albendazole (follow-up) for Ascaris lumbricoides (panel A), Trichuris trichiura (panel B) and hookworm (panel C) in Ethiopia, Lao PDR and Pemba Island (Tanzania). The boxplots show the median, interquartile range, 5th and 95th percentiles of the data. Grey lines join mean fecal egg counts measured from the same individual.
Fig 2. Individual therapeutic efficacy of albendazole…
Fig 2. Individual therapeutic efficacy of albendazole against soil-transmitted helminth infections estimated in three study sites.
The individual-based therapeutic efficacy is expressed as the reduction in fecal egg counts (FECs) following drug administration (egg reduction rate, ERRi) and was estimated by fitting the Bayesian model [15,16,21] to FEC data on Ascaris lumbricoides (panel A), Trichuris trichiura (panel B) and hookworm (panel C) collected before and after administration of a single 400 mg oral dose of albendazole in three study sites, Ethiopia, Lao PDR and Pemba Island (Tanzania). Each cross denotes the posterior median of ERRi and horizontal lines denote 95% credible intervals. The estimates are ordered according to the percentile of the estimated median ERRi. The areas shaded in orange, yellow and blue denote, respectively, the World Health Organization categories for ‘reduced’, ‘doubtful’ and ‘satisfactory’ population-based therapeutic efficacy (ERRP, which differ for each infection). Negative estimates of ERRi correspond to FECs that increased after administration of albendazole.
Fig 3. Coefficients of fixed effects terms…
Fig 3. Coefficients of fixed effects terms associated with the efficacy of albendazole against soil-transmitted helminth infections.
Coefficients were estimated by fitting the Bayesian model [15,16,21] to fecal egg count data on Ascaris lumbricoides (panel A), Trichuris trichiura (panel B) and hookworm (panel C) collected before and after administration of a single 400 mg oral dose of albendazole in three study sites, Ethiopia, Lao PDR and Pemba Island (Tanzania). Points, horizontal thick and thin lines indicate the median, the 50% and the 95% credible interval respectively. The reference category of each variable is indicated by a point on the vertical line (Ethiopia; female; age 6–9 years; follow up >2 weeks and no coinfection). Positive coefficients indicate a lower individual egg reduction rate, ERRi. Negative coefficients indicate a higher ERRi.
Fig 4. Influence of fixed effects coefficients…
Fig 4. Influence of fixed effects coefficients on the efficacy of albendazole against soil-transmitted helminth infections.
Individual egg reduction rates, ERRi, were estimated by fitting the Bayesian model [15,16,21] to fecal egg count data on Ascaris lumbricoides (panel A), Trichuris trichiura (panel B) and hookworm (panel C) collected before and after administration of a single 400 mg oral dose of albendazole in three study sites, Ethiopia, Lao PDR and Pemba Island (Tanzania). Points, horizontal thick and thin lines indicate the median, the 50% and the 95% credible interval respectively. The reference ERRi (i.e., with fixed effects set to the reference categories of Ethiopia, female, age 6–9 years, follow up >2 weeks and no coinfection) is indicated by the solid vertical line. All estimates correspond to the ERRi associated with a ‘typical individual’ (i.e., with random effects terms set to 0).
Fig 5. Correlation between the intensity of…
Fig 5. Correlation between the intensity of infection before drug administration and the efficacy of albendazole against soil-transmitted helminth infections.
Correlation coefficients were estimated by fitting the Bayesian model [15,16,21] to fecal egg count data on Ascaris lumbricoides (panel A), Trichuris trichiura (panel B) and hookworm (panel C) collected before and after administration of a single 400 mg oral dose of albendazole in three study sites, Ethiopia, Lao PDR and Pemba Island (Tanzania).

References

    1. World Health Organization. Schistosomiasis and soil-transmitted helminthiases: number of people treated in 2018. Wkly Epidemiol Rec. 2019;50:601–12.
    1. World Health Organization. Ending the neglect to attain the sustainable development goals: A road map for neglected tropical diseases 2021–2030. Geneva: World Health Organization, 2020.
    1. World Health Organization. Crossing the billion. Lymphatic filariasis, onchocerciasis, soil-transmitted helminthiases and trachoma: preventive chemotherapy for neglected tropical diseases. Genva: World Health Organization, 2017.
    1. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000;121 Suppl:S113–32. Epub 2001/06/02. doi: 10.1017/s0031182000007290
    1. Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop. 2003;86(2–3):141–59. Epub 2003/05/15. doi: 10.1016/s0001-706x(03)00031-7
    1. World Health Organization. Preventive chemotherapy in human helminthiasis: coordinated use of anthelmintic drugs in control interventions—a manual for health professionals and programme managers. Geneva: World Health Organization, 2006.
    1. Moser W, Schindler C, Keiser J. Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis. BMJ. 2017;358:j4307. Epub 2017/09/28. doi: 10.1136/bmj.j4307
    1. Levecke B, Brooker SJ, Knopp S, Steinmann P, Sousa-Figueiredo JC, Stothard JR, et al.. Effect of sampling and diagnostic effort on the assessment of schistosomiasis and soil-transmitted helminthiasis and drug efficacy: a meta-analysis of six drug efficacy trials and one epidemiological survey. Parasitology. 2014;141(14):1826–40. Epub 2014/04/15. doi: 10.1017/S0031182013002266
    1. Steinmann P, Utzinger J, Du ZW, Jiang JY, Chen JX, Hattendorf J, et al.. Efficacy of single-dose and triple-dose albendazole and mebendazole against soil-transmitted helminths and Taenia spp.: a randomized controlled trial. PLoS One. 2011;6(9):e25003. Epub 2011/10/08. doi: 10.1371/journal.pone.0025003
    1. Patel C, Coulibaly JT, Schulz JD, N’Gbesso Y, Hattendorf J, Keiser J. Efficacy and safety of ascending dosages of albendazole against Trichuris trichiura in preschool-aged children, school-aged children and adults: A multi-cohort randomized controlled trial. EClinicalMedicine. 2020;22:100335. Epub 2020/05/15. doi: 10.1016/j.eclinm.2020.100335
    1. Mekonnen Z, Levecke B, Boulet G, Bogers JP, Vercruysse J. Efficacy of different albendazole and mebendazole regimens against heavy-intensity Trichuris trichiura infections in school children, Jimma Town, Ethiopia. Pathog Glob Health. 2013;107(4):207–9. Epub 2013/07/03. doi: 10.1179/2047773213Y.0000000092
    1. Albonico M, Bickle Q, Ramsan M, Montresor A, Savioli L, Taylor M. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Organ. 2003;81(5):343–52. Epub 2003/07/12.
    1. Levecke B, Easton AV, Cools P, Albonico M, Ame S, Gilleard JS, et al.. The optimal timing of post-treatment sampling for the assessment of anthelminthic drug efficacy against Ascaris infections in humans. Int J Parasitol Drugs Drug Resist. 2018;8(1):67–9. Epub 2018/02/08. doi: 10.1016/j.ijpddr.2017.12.004
    1. Denwood MJ, Innocent G.T., Prentice JC, Matthews L, Reid SWJ, Pipper CB, et al.. A hypothesis testing framework for the ratio of means of two negative binomial distributions: classifying the efficacy of anthelmintic treatment against intestinal parasites. 2019.
    1. Walker M, Mabud TS, Olliaro PL, Coulibaly JT, King CH, Raso G, et al.. New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel. Parasit Vectors. 2016;9:41. Epub 2016/01/28. doi: 10.1186/s13071-016-1312-0
    1. Walker M, Churcher TS, Basáñez M-G. Models for measuring anthelmintic drug efficacy for parasitologists. Trends Parasitol. 2014;30(11):528–37. Epub 2014/09/15. doi: 10.1016/j.pt.2014.08.004
    1. World Health Organization. Assessing the efficacy of anthelmintic drugs against schistosomiasis and soil-transmitted helminthiases. Geneva: World Health Organization, 2013.
    1. Cools P, Vlaminck J, Albonico M, Ame S, Ayana M, Jose Antonio BP, et al.. Diagnostic performance of a single and duplicate Kato-Katz, Mini-FLOTAC, FECPAKG2 and qPCR for the detection and quantification of soil-transmitted helminths in three endemic countries. PLoS Negl Trop Dis. 2019;13(8):e0007446. Epub 2019/08/02. doi: 10.1371/journal.pntd.0007446
    1. Vlaminck J, Cools P, Albonico M, Ame S, Ayana M, Cringoli G, et al.. Therapeutic efficacy of albendazole against soil-transmitted helminthiasis in children measured by five diagnostic methods. PLoS Negl Trop Dis. 2019;13(8):e0007471. Epub 2019/08/02. doi: 10.1371/journal.pntd.0007471
    1. Vlaminck J, Cools P, Albonico M, Ame S, Ayana M, Bethony J, et al.. Comprehensive evaluation of stool-based diagnostic methods and benzimidazole resistance markers to assess drug efficacy and detect the emergence of anthelmintic resistance: A Starworms study protocol. PLoS Negl Trop Dis. 2018;12(11):e0006912. Epub 2018/11/06. doi: 10.1371/journal.pntd.0006912
    1. Crellen T, Walker M, Lamberton PH, Kabatereine NB, Tukahebwa EM, Cotton JA, et al.. Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration. Clin Infect Dis. 2016;63(9):1151–9. Epub 2016/07/30. doi: 10.1093/cid/ciw506
    1. Cools P, Vlaminck J, Verweij JJ, Levecke B. Quantitative PCR in soil-transmitted helminth epidemiology and control programs: Toward a universal standard. PLoS Negl Trop Dis. 2021;15(3):e0009134. Epub 2021/03/05. doi: 10.1371/journal.pntd.0009134
    1. Efron B, Tibshirani R. An Introduction to the Bootstrap. London: Chapman & Hall/CRC; 1993.
    1. Stan Development Team. Stan Modeling Language Users Guide and Reference Manual, version 2.26. 2020.
    1. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2019.
    1. Bürkner P-C. Advanced Bayesian multilevel modeling with the R: package brms. R J. 2018;10:395–411. doi: 10.32614/RJ-2018-017
    1. Bürkner P-C. brms: An R packages for Bayesian multilevel models using Stan. J Stat Softw. 2017;80:1–28. doi: 10.18637/jss.v080.i01
    1. Speich B, Ame SM, Ali SM, Alles R, Huwyler J, Hattendorf J, et al.. Oxantel pamoate-albendazole for Trichuris trichiura infection. N Engl J Med. 2014;370(7):610–20. Epub 2014/02/14. doi: 10.1056/NEJMoa1301956
    1. Speich B, Ame SM, Ali SM, Alles R, Hattendorf J, Utzinger J, et al.. Efficacy and safety of nitazoxanide, albendazole, and nitazoxanide-albendazole against Trichuris trichiura infection: a randomized controlled trial. PLoS Negl Trop Dis. 2012;6(6):e1685. Epub 2012/06/09. doi: 10.1371/journal.pntd.0001685
    1. Knopp S, Mohammed KA, Speich B, Hattendorf J, Khamis IS, Khamis AN, et al.. Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial. Clin Infect Dis. 2010;51(12):1420–8. Epub 2010/11/11. doi: 10.1086/657310
    1. Kotze AC, Kopp SR. The potential impact of density dependent fecundity on the use of the faecal egg count reduction test for detecting drug resistance in human hookworms. PLoS Negl Trop Dis. 2008;2(10):e297. Epub 2008/10/02. doi: 10.1371/journal.pntd.0000297
    1. Vercruysse J, Behnke JM, Albonico M, Ame SM, Angebault C, Bethony JM, et al.. Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic. PLoS Negl Trop Dis. 2011;5(3):e948. Epub 2011/04/07. doi: 10.1371/journal.pntd.0000948
    1. Turner HC, Truscott JE, Bettis AA, Hollingsworth TD, Brooker SJ, Anderson RM. Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of Trichuris trichiura. Parasite Epidemiol Control. 2016;1(2):177–87. Epub 2016/07/19. doi: 10.1016/j.parepi.2016.02.004
    1. Palmeirim MS, Hurlimann E, Knopp S, Speich B, Belizario V Jr., Joseph SA, et al.. Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis. PLoS Negl Trop Dis. 2018;12(4):e0006458. Epub 2018/04/28. doi: 10.1371/journal.pntd.0006458
    1. Speich B, Ali SM, Ame SM, Bogoch II, Alles R, Huwyler J, et al.. Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled trial. Lancet Infect Dis. 2015;15(3):277–84. Epub 2015/01/16. doi: 10.1016/S1473-3099(14)71050-3
    1. World Health Organization. Seventh meeting of the working group on monitoring of neglected tropical diseases drug efficacy. Geneva: World Health Organization, 2018.
    1. Geerts S, Gryseels B. Drug resistance in human helminths: current situation and lessons from livestock. Clin Microbiol Rev. 2000;13(2):207–22. Epub 2001/02/07. doi: 10.1128/CMR.13.2.207
    1. Halder JB, Benton J, Julé AM, Guérin PJ, Olliaro PL, Basáñez M-G, et al.. Systematic review of studies generating individual participant data on the efficacy of drugs for treating soil-transmitted helminthiases and the case for data-sharing. PLoS Negl Trop Dis. 2017;11(10):e0006053. Epub 2017/11/01. doi: 10.1371/journal.pntd.0006053
    1. Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC. Drug resistance in veterinary helminths. Trends Parasitol. 2004;20(10):469–76. Epub 2004/09/15. doi: 10.1016/j.pt.2004.07.010
    1. Nsanzabana C, Djalle D, Guérin PJ, Menard D, Gonzalez IJ. Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape. Malar J. 2018;17(1):75. Epub 2018/02/10. doi: 10.1186/s12936-018-2185-9
    1. Karunajeewa HA. Parasite clearance after malaria therapy: staying a step ahead of drug resistance. BMC Med. 2015;13:251. Epub 2015/10/03. doi: 10.1186/s12916-015-0486-1
    1. Sibley CH, Guérin PJ, Ringwald P. Monitoring antimalarial resistance: launching a cooperative effort. Trends Parasitol. 2010;26(5):221–4. Epub 2010/03/23. doi: 10.1016/j.pt.2010.02.008
    1. Saito M, Mansoor R, Kennon K, Anvikar AR, Ashley EA, Chandramohan D, et al.. Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis. Lancet Infect Dis. 2020. Epub 2020/06/13. doi: 10.1016/S1473-3099(20)30064-5
    1. WWARN Gametocyte Study Group. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med. 2016;14:79. Epub 2016/05/26. doi: 10.1186/s12916-016-0621-7

Source: PubMed

3
Abonneren